Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. X:X | DOI: 10.5507/bp.2025.033
20-year experience with laparoscopic adrenalectomy at a high-volume center
- 1 Department of Urology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
- 2 Department of Radiology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
- 3 Department of Internal Medicine III – Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
Objective: To evaluate transperitoneal laparoscopic adrenalectomies performed at the University Hospital, Olomouc over a period of 20 years.
Introduction: Thanks to the increased availability of imaging, the detection of adrenal disease is increasing. Laparoscopic adrenalectomy is now regarded as the gold standard for the treatment of adrenal disease due to its safety and efficacy despite the increasing popularity of robotic-assisted surgery.
Methods: Over a period of 20 years, from 2002 to 2021, we retrospectively evaluated a cohort of 405 patients who had undergone laparoscopic adrenalectomy. The indication criteria for laparoscopic adrenalectomy were hormonally active symptomatic tumours (pheochromocytoma, Conn's syndrome, Cushing's syndrome, etc.), symptomatic cysts or myelolipomas, carcinomas, metastatic disabling or incidentalomas, growing at a rate >1 cm or more per year. Data collected focused on sex, age, medical classification, imaging, operative time, side dominance, hormonal activity, complications associated with surgery, length of hospital stay, and histopathologic verification. No patient who had undergone laparoscopic adrenalectomy was excluded from the cohort. Patients in our cohort were not operated by a single surgeon.
Results: Women accounted for 52.1% (211) and men 47.9% (194). The mean age was 55.6 years, BMI 28.7, and median ASA score was 2. Preoperative imaging included abdominal CT in 352 (86.9%) patients, abdominal MRI with contrast agent in 8 (2.0%), and PET/CT in 45 (11.1%) patients. More frequent findings were on the right side in 223 (54.39%) patients. Hormonal activity was found in 271 patients (67 %). Hormone overproduction from the right adrenal gland was found in 120 (44.3%) patients, and from the left in 151 (55.7%). Adenoma was the most frequent histological finding, followed by hyperplasia. Conversion to open surgery was due to bleeding in 2 patients. There was no perioperative or postoperative mortality. According to the Clavien-Dindo classification, minor complications (Grade I) occurred in 375 patients (92.6%). Grade II complications were reported in 17 patients (4.2%). Grade III complications were identified in 13 patients (3.2%) due to operative field bleeding; in three cases (0.7%), surgical revision of the adrenalectomy bed was required.
Conclusion: Laparoscopic adrenalectomy is a safe surgical method for the management of adrenal disease and our retrospective follow-up confirmed that it remains the gold standard.
Keywords: laparoscopic adrenalectomy, adrenal, tumours, functional adrenal tumours, demographics
Received: September 5, 2025; Revised: November 23, 2025; Accepted: November 28, 2025; Prepublished online: January 8, 2026
References
- Bourdeau I, El Ghorayeb N, Gagnon N, Management of endocrine disease: differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas. Eur J Endocrinol 2018;179(2):R57-67.
Go to original source... - Mihai R, Donatini G, Vidal O, Brunaud L, Volume-outcome correlation in adrenal surgery - an ESES consensus statement. Langenbecks Arch Surg 2019;404(6):795-806.
Go to original source... - Gagner M, Lacroix A, Bolte E, Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med 1992;327(11):1033-7.
Go to original source... - Horgan S, Vanuno D, Robots in laparoscopic surgery. J Laparoendosc Adv Surg Tech A 2001;11(6):415-9.
Go to original source... - Rossi GP, Update in adrenal venous sampling for primary aldosteronism. Curr Opin Endocrinol Diabetes Obes 2018;25(3):160-71.
Go to original source... - Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J, Naruse M, Deinum J, Schultzekool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Rump LC, Vonend O, Willenberg HS, Fuller P, Yang J, Nian Chee NY, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Chang CC, Wu VC, Somloova Z, Maiolino G, Barbiero G, Battistel M, Lenzini L, Quaia E, Pessina AC, Rossi GP. Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization. J Clin Endocrinol Metab 2020;105(6):dgz017. doi: 10.1210/clinem/dgz017
Go to original source...
Go to PubMed... - Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF Jr. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016;101(5):1889-916. doi: 10.1210/jc.2015-4061. Erratum in: J Clin Endocrinol Metab 2025;110(10):e3549. doi: 10.1210/clinem/dgaf445
Go to original source...
Go to PubMed... - Yang J, Bell DA, Carroll R, Chiang C, Cowley D, Croker E, Doery JCG, Elston M, Glendenning P, Hetherington J, Horvath AR, Lu-Shirzad S, Ng E, Mather A, Perera N, Rashid M, Sachithanandan N, Shen J, Stowasser M, Swarbrick MJ, Tan HLE, Thuzar M, Young S, Chong W. Adrenal Vein Sampling for Primary Aldosteronism: Recommendations From the Australian and New Zealand Working Group. Clin Endocrinol (Oxf) 2025;102(1):31-43. doi: 10.1111/cen.15139
Go to original source...
Go to PubMed... - Rossi GP, Battistel M, Seccia TM, Rossi FB, Rossitto G. Subtyping of Primary Aldosteronism by Adrenal Venous Sampling. Endocr Rev 2025;46(4):501-20.
Go to original source... - Thipbumrung S, Manosroi W. Adrenal venous sampling outcomes with and without mineralocorticoid receptor antagonist continuation. BMC Endocr Disord 2025;25:19.
Go to original source... - Taïeb D, Hicks RJ, Hindié E, Guillet BA, Avram A, Ghedini P, Timmers HJ, Scott AT, Elojeimy S, Rubello D, Virgolini IJ, Fanti S, Balogová S, Pandit-Taskar N, Pacak K. EANM/SNMMI practice guideline for radionuclide imaging of pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging 2019;46(12):2112-37.
Go to original source... - Pacak K, Taïeb D. New imaging approaches to pheochromocytomas and paragangliomas. Endocr Relat Cancer 2010;17(2):R53-R83.
- Jansen T, Carrasquillo JA, Chen CC, Jha A, Ling A, Lin FI, Pryma DA, Pacak K. Imaging of pheochromocytomas and paragangliomas. J Nucl Med 2021;62(8):1033-40.
Go to original source... - Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplô AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF. Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014;99(6):1915-42.
Go to original source... - Sung C, Lee HS, Lee DY, Ryu JS, Rufini V, Lee JK, Lee JN, Choi SH, Kim YI, Kim BT, Jung SJ. A prospective comparative study of 18F-FDOPA PET/CT versus 123I-MIBG scintigraphy in PPGL. Eur J Nucl Med Mol Imaging 2004;31(11):1295-301.
- Takenaka J, Watanabe S, Abe T, Takeuchi S, Hirata K, Kimura R, Ishii H, Wakabayashi N, Majigsuren M, Kudo K. The Biochemical-Imaging Connection: Urinary Noradrenaline and Fluorodeoxyglucose-Positron Emission Tomography in Unresectable or Metastatic Pheochromocytomas and Paragangliomas. Diagnostics (Basel) 2025;15(11):1305. doi: 10.3390/diagnostics15111305
Go to original source...
Go to PubMed... - Fassnacht M, Arlt W, Bancos I, Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline. Eur J Endocrinol 2023;188(5):G1-G28.
Go to original source... - Nieman LK, Biller BMK, Findling JW, The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008;93(5):1526-40.
- Danwang C, Agbor VN, Bigna JJ, Obesity and postoperative outcomes of the patients with laparoscopic adrenalectomy: a systematic review and meta-analysis. BMC Surg 2020;20(1):194.
Go to original source... - Silvinato A, Bernardo WM, Branco AW, Total and partial laparoscopic adrenalectomy. Rev Assoc Med Bras 2019;65(5):578-85.
Go to original source... - Duralska M, Kalinowski T, Szydelko J, High-volume center experience with laparoscopic adrenalectomy over two decades. J Clin Med 2022;11(9):2335.
Go to original source... - Teksoz S, Kilboz BB, Bukey Y, Experience of an endocrine surgeon in laparoscopic transperitoneal adrenalectomy. Ann Med Surg (Lond) 2019;45:33-7.
Go to original source... - Cavallaro G, De Toma G, Mingazzini P, Polistena A, Surgical management of adrenocortical carcinoma: current highlights. Biomedicines 2021;9(8):909.
Go to original source... - Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016;101(5):1889-916.
Go to original source... - Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A, Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress. World J Surg 2006;30(5):872-8.
Go to original source... - Mihai R, Donatini G, Vidal O, Brunaud L, Volume-outcome correlation in adrenal surgery: an ESES consensus statement. Langenbecks Arch Surg 2019;404(6):795-806.
Go to original source... - Nomine-Criqui C, Germain A, Ayav A, Klein M, Brunaud L, Robot-assisted adrenalectomy: indications and drawbacks. Updates Surg 2017;69(1):127-33.
Go to original source...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.




